Basilea Pharmaceutica Ltd (0QNA)
Market Closed
15 Oct, 03:30 PM
LSE 
68. 60
CHF +1.9
+2.8486%
- Market Cap
7.96 P/E Ratio
20% Div Yield
508 Volume
2.9 Eps
66.7 CHF
Previous Close Want to track 0QNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Basilea Pharmaceutica Ltd (0QNA) Statistics
Valuation metrics
Market Cap -
Enterprise value 718.13M
Trailing P/E (ttm) 15.38
Forward P/E -
PEG ratio -1.26
Price/Sales (ttm) 3.28
Price/Book (mrq) 4.99
Enterprise Value/Revenue 2.9
Enterprise Value/EBITDA 11.28
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.69K
Average volume (90 days) 16.5K
Price summary
52-Week low 44.7
52-Week high 70.4
Beta -
50-Day moving average 66.32
200-Day moving average 56.38
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 21 Jun 2013
Ex-Dividend Date 11 Apr 2013
Last split factor 1,039:1,029
Last split Date 13 Mar 2007
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.21%
Operating margin 0.24%
Operational effectiveness
Return on assets 0.18%
Return on equity 0.36%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 20
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 4.23
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 14.23
Total debt (mrq) -
Total Debt/Equity (mrq) 0.51
Current ratio (mrq) 6.6%
Book value per share (mrq) 13.12
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
